2DPA-1の市場規模、シェア、成長分析：用途別、最終用途別、地域別 - 産業予測 2025～2032年

2DPA-1市場規模は2023年に6,654億4,000万米ドルと評価され、予測期間（2025-2032年）のCAGRは3.8%で、2024年の6,907億3,000万米ドルから2032年には9,308億6,000万米ドルに成長する見通しです。

2DPA-1の世界市場は、医薬品、農薬、染料製造、パーソナルケアなど、さまざまな分野でのこの化合物の多目的な用途に牽引され、増加の一途をたどっています。ユニークな特性で知られる2DPA-1（2-ジフェニルアセチル-1,3-インダンジオン）は、多くの製剤において重要な化学中間体として機能し、スキンケア製品におけるアンチエイジングや抗酸化作用などの有益な特性で賞賛されています。多様な産業におけるこの需要の高まりは、革新的なソリューションの活用を目指す市場関係者にとって大きな成長の可能性を強調するものです。さらに、米国の2DPA-1市場は今後1年間も持続的なCAGRを維持すると予測されており、このダイナミックな分野への投資と市場開発の好機であることを浮き彫りにしています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 規制情勢
• 特許分析

2DPA-1市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 医薬品
• 農薬品
• 化粧品
• その他

2DPA-1市場規模：最終用途別& CAGR（2025-2032）

• 市場概要
• ヘルスケア
• 繊維・染料
• その他

2DPA-1市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Siemens AG（Germany）
• GE Healthcare（United States）
• Philips Healthcare（Netherlands）
• Canon Medical Systems Corporation（Japan）
• Hitachi, Ltd.（Japan）
• Toshiba Medical Systems Corporation（Japan）
• Koninklijke Philips N.V.（Netherlands）
• Fujifilm Holdings Corporation（Japan）
• Carestream Health, Inc.（United States）
• Esaote SpA（Italy）
• Samsung Medison Co., Ltd.（South Korea）
• Hologic, Inc.（United States）
• Mindray Medical International Limited（China）
• Agfa-Gevaert NV（Belgium）
• Shimadzu Corporation（Japan）
• CurveBeam LLC（United States）
• Planmed Oy（Finland）
• Medtronic plc（Ireland）
• Varian Medical Systems, Inc.（United States）
• Epiroc AB（Sweden）

結論と提言

2DPA-1 Market size was valued at USD 665.44 billion in 2023 and is poised to grow from USD 690.73 billion in 2024 to USD 930.86 billion by 2032, growing at a CAGR of 3.8% during the forecast period (2025-2032).

The global 2DPA-1 market is on the rise, driven by the compound's versatile applications in various sectors, including pharmaceuticals, agrochemicals, dye production, and personal care. Known for its unique properties, 2DPA-1 (2-diphenylacetyl-1,3-indandione) serves as a critical chemical intermediate in many formulations and is praised for its beneficial attributes like anti-aging and antioxidant effects in skincare products. This escalating demand across diverse industries underscores significant growth potential for market players looking to leverage innovative solutions. Furthermore, the US 2DPA-1 market is anticipated to maintain a sustainable CAGR in the coming forecast year, highlighting an opportune moment for investment and development in this dynamic sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the 2DPA-1 market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

2DPA-1 Market Segments Analysis

Global 2DPA-1 Market is segmented by Application, End Use and region. Based on Application, the market is segmented into Pharmaceuticals, Agrochemicals, Cosmetics and Others. Based on End Use, the market is segmented into Healthcare, Textile & Dye and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the 2DPA-1 Market

The pharmaceutical sector is perpetually on the lookout for new and groundbreaking drug candidates to tackle diverse health issues. The distinctive therapeutic attributes of 2DPA-1-encompassing anti-inflammatory, anti-cancer, and antiviral properties-are propelling its utilization in drug discovery and development. This increasing interest and reliance on 2DPA-1 are contributing to a notable cumulative annual growth rate (CAGR) for the global market of 2DPA-1 over the projected timeframe. As the demand for effective treatments escalates, 2DPA-1 stands out as a promising candidate, further stimulating its integration into various therapeutic applications and solidifying its position within the pharmaceutical landscape.

Restraints in the 2DPA-1 Market

The emergence of new entrants in both regional and global markets may enhance competitiveness, potentially jeopardizing the positions of established players. As these newcomers introduce innovative products and diversify their offerings, existing businesses must adapt and refine their strategies to maintain market share. A robust and improved product portfolio from competitors could heighten the stakes, prompting a more aggressive approach to marketing and innovation among current players. This dynamic landscape necessitates that established firms continually assess their value propositions and respond effectively to the challenges posed by fresh market participants, ensuring their sustainability and growth in an increasingly competitive environment.

Market Trends of the 2DPA-1 Market

The 2DPA-1 market is currently facing a trend characterized by its intricate and costly production processes, which impede its broader adoption across industries. As manufacturers grapple with high production costs, the economic viability of 2DPA-1 becomes a significant concern, potentially limiting its accessibility and affordability. This financial barrier could hinder market expansion, resulting in a relatively modest compound annual growth rate (CAGR) throughout the forecast period. Despite its potential applications, the complexity of 2DPA-1 manufacturing may deter widespread usage, making it essential for industry players to innovate and streamline production techniques to boost market growth.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global 2DPA-1 Market Size by Application & CAGR (2025-2032)

• Market Overview
• Pharmaceuticals
• Agrochemicals
• Cosmetics
• Others

Global 2DPA-1 Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Healthcare
• Textile & Dye
• Others

Global 2DPA-1 Market Size & CAGR (2025-2032)

• North America (Application, End Use)
  • US
  • Canada
• Europe (Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Siemens AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hitachi, Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Toshiba Medical Systems Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carestream Health, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Esaote SpA (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samsung Medison Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray Medical International Limited (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agfa-Gevaert NV (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shimadzu Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CurveBeam LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Planmed Oy (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Varian Medical Systems, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Epiroc AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations